Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tianjin Pharmaceutical Da Ren Tang Group has announced the completion of its disposal of a 13% equity interest in Tianjin TSKF Pharmaceutical Co., Ltd. to Haleon China Co., Ltd. This strategic move, classified as an interested person transaction, reflects the company’s efforts to optimize its investment portfolio and potentially enhance shareholder value.
For further insights into SG:T14 stock, check out TipRanks’ Stock Analysis page.